Alpha BioAdvisors™ Forecasts
IBB ETF & XBI ETF FORECASTS
Forecasting the IBB ETF and the XBI ETF through the lens of macro factors and top company components driving price using fundamental and technical analyses.
Valuation View
Analyzing the external drivers of biotech valuation – macro, interest rates, government policies, regulatory, reimbursement/payors, politics, patents and technology.
Are you taking a long-term position in a stock? Evaluate it and reevaluate it as the discount rate changes. Using the right discount rate could make or break your investment. Every month we examine a driver of biotech valuation.
Are you using the right discount rate for your next project, product, acquisition? Using the right discount rate can make all the difference in a new project commitment and for an acquisition. Be certain you are properly characterizing your valuation on the Street as you plan your next transaction and after key licensing and acquisition deals.
Stay up to date with what is driving biotech valuation. Where is value heading – Who is capturing its – Why & How
Sign up now for our monthly Valuation View